Cargando…

Intratumoral expression of CCR3 in breast cancer is associated with improved relapse-free survival in luminal-like disease

PURPOSE: The association chemokine receptor CCR3 with breast cancer subtypes and relapse-free survival is unknown. RESULTS: The overall expression (either intratumoral or peritumoral) of CCR3 was not associated with tumor size, lymph node status, age, and subtype. When we confined the analysis in sa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Di-He, Fan, Lei, Chen, Hai-Yan, Ding, Ke-Feng, Yu, Ke-Da
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053746/ https://www.ncbi.nlm.nih.gov/pubmed/27086913 http://dx.doi.org/10.18632/oncotarget.8680

Ejemplares similares

GRHL2 motif is associated with intratumor heterogeneity of cis-regulatory elements in luminal breast cancer
por: Kumegawa, Kohei, et al.
Publicado: (2022)

CCR4 Blockade Diminishes Intratumoral Macrophage Recruitment and Augments Survival of Syngeneic Pancreatic Cancer-Bearing Mice
por: Khabipov, Aydar, et al.
Publicado: (2023)

Intratumoral Heterogeneity of Expression of 16 miRNA in Luminal Cancer of the Mammary Gland
por: Veryaskina, Yuliya A., et al.
Publicado: (2020)

Characterizing the Relapse Potential in Different Luminal Subtypes of Breast Cancers with Functional Proteomics
por: Lin, Tung-Yi, et al.
Publicado: (2020)

CCR7 Expression and Intratumoral FOXP3(+) Regulatory T Cells are Correlated with Overall Survival and Lymph Node Metastasis in Gastric Cancer
por: Zhou, Shuang, et al.
Publicado: (2013)

Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9(+) T cells
por: Chen, Hongmei, et al.
Publicado: (2020)

Nomograms to estimate long-term overall survival and breast cancer-specific survival of patients with luminal breast cancer
por: Sun, Wei, et al.
Publicado: (2016)

Dynamic contrast-enhanced magnetic resonance imaging radiomics analysis based on intratumoral subregions for predicting luminal and nonluminal breast cancer
por: Feng, Shuqian, et al.
Publicado: (2023)

Correction: CCR7 Expression and Intratumoral FOXP3(+) Regulatory T Cells are Correlated with Overall Survival and Lymph Node Metastasis in Gastric Cancer
Publicado: (2014)

A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer
por: Bonneau, Claire, et al.
Publicado: (2020)

Survival outcomes are associated with genomic instability in luminal breast cancers
por: King, Lydia, et al.
Publicado: (2021)

Relapse-free survival in Sudanese women with non-metastatic breast cancer
por: Muddather, Hiba Faroug, et al.
Publicado: (2022)

Ki-67 (30-9) scoring and differentiation of Luminal A- and Luminal B-like breast cancer subtypes
por: Viale, Giuseppe, et al.
Publicado: (2019)

Common profiles of Notch signaling differentiate disease-free survival in luminal type A and triple negative breast cancer
por: Orzechowska, Magdalena, et al.
Publicado: (2016)

The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas
por: Herschkowitz, Jason I, et al.
Publicado: (2008)

SUN-122 Nuclear PDCD4 Expression Predicts Good Clinical Outcome in Luminal A-Like and Luminal B-Like Breast Cancer Subtypes
por: Madera, Santiago, et al.
Publicado: (2020)

Chemoradiotherapy Increases Intratumor Heterogeneity of HPSE Expression in the Relapsed Glioblastoma Tumors
por: Suhovskih, Anastasia V., et al.
Publicado: (2020)

Prognostic Value of Lymphangiogenesis Determinants in Luminal and Non-luminal Breast Carcinomas
por: Widodo, Irianiwati, et al.
Publicado: (2018)

Perianal and Luminal Relapse Following Perianal Surgical Intervention in Crohn’s Disease
por: Deng, Feihong, et al.
Publicado: (2021)

LGR5 overexpression confers poor relapse-free survival in breast cancer patients
por: Hou, Ming-Feng, et al.
Publicado: (2018)

Survival analysis of bevacizumab plus taxane treatment in luminal metastatic breast cancer
por: Murillo, Serafin Morales, et al.
Publicado: (2021)

Protein-based immune profiles of basal-like vs. luminal breast cancers
por: Walens, Andrea, et al.
Publicado: (2021)

Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and Immunotherapy
por: Blinova, Ekaterina, et al.
Publicado: (2020)

Intratumoral CCR5(+) neutrophils identify immunogenic subtype muscle-invasive bladder cancer with favorable prognosis and therapeutic responses
por: Xiang, Zhuoyi, et al.
Publicado: (2020)

The influence of dimming-induced luminance change on driving safety in tunnels
por: Zhang, Chi, et al.
Publicado: (2023)

A three-gene signature marks the time to locoregional recurrence in luminal-like breast cancer
por: Chiodoni, C., et al.
Publicado: (2023)

Neuroligin 4X overexpression in human breast cancer is associated with poor relapse-free survival
por: Henderson, Henry J., et al.
Publicado: (2017)

Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer
por: Li, Yilun, et al.
Publicado: (2021)

Quantification of subtype purity in Luminal A breast cancer predicts clinical characteristics and survival
por: Kumar, Neeraj, et al.
Publicado: (2023)

Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer
por: Varkaris, Andreas, et al.
Publicado: (2019)

Application of DCE-MRI radiomics signature analysis in differentiating molecular subtypes of luminal and non-luminal breast cancer
por: Huang, Ting, et al.
Publicado: (2023)

Association between mammographic density and basal-like and luminal A breast cancer subtypes
por: Razzaghi, Hilda, et al.
Publicado: (2013)

Identification and Validation of Oncologic miRNA Biomarkers for Luminal A-like Breast Cancer
por: McDermott, Ailbhe M., et al.
Publicado: (2014)

Isolation and characterization of a new basal-like luminal progenitor in human breast tissue
por: Bhat, Vasudeva, et al.
Publicado: (2019)

Circulating biomarkers at diagnosis correlate with distant metastases of early luminal-like breast cancer
por: Lambrechts, Yentl, et al.
Publicado: (2023)

Molecular heterogeneity of luminal breast cancer
por: Loi, S
Publicado: (2011)

Estrogen response in luminal breast cancer
por: Rangel, Leticia B. A., et al.
Publicado: (2013)

Luminal B subtype: A key factor for the worse prognosis of young breast cancer patients in China
por: Tang, Li-Chen, et al.
Publicado: (2015)

Molecular Mechanism of Secondary Endocrine Resistance in Luminal Breast Cancer
por: Wu, Minhua, et al.
Publicado: (2021)

Identification of methylation sites and signature genes with prognostic value for luminal breast cancer
por: Xiao, Bin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_im32tpq7nec1rv69javdj3cd06